Fig 1. The annual HIV incidence per 100,000 population ages 15 to 65 when antiretroviral therapy coverage is 70% and pre-exposure prophylaxis coverage is 20% with and without adolescents ages 15 through 17 included in the uptake of pre-exposure prophylaxis and the annual HIV incidence per 100,000 population ages 15 to 65 when antiretroviral therapy coverage is 90% and pre-exposure prophylaxis coverage is 40% with and without adolescents ages 15 through 17 included in the uptake of pre-exposure prophylaxis.